Group One Trading
ECYT

Group One Trading’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Group One Trading’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-66,800
Closed -$1.19M – 5808
2018
Q3 		$1.19M Buy
66,800
+4,000
+6% +$68.7K 0.01% 1566
2018
Q2 		$867K Sell
62,800
-184,800
-75% -$2.19M 0.01% 1854
2018
Q1 		$2.25M Buy
247,600
+222,100
+871% +$1.23M 0.02% 928
2017
Q4 		$109K Buy
25,500
+12,500
+96% +$59.6K ﹤0.01% 3314
2017
Q3 		$18K Hold
13,000
– – ﹤0.01% 4119
2017
Q2 		$20K Sell
13,000
-2,200
-14% -$4.72K ﹤0.01% 3953
2017
Q1 		$39K Sell
15,200
-25,400
-63% -$58.8K ﹤0.01% 3571
2016
Q4 		$104K Sell
40,600
-9,800
-19% -$28.1K ﹤0.01% 2827
2016
Q3 		$156K Buy
50,400
+24,800
+97% +$77.3K ﹤0.01% 2645
2016
Q2 		$82K Buy
25,600
+25,000
+4,167% +$91.6K ﹤0.01% 2997
2016
Q1 		$2K Sell
600
-2,100
-78% -$6.86K ﹤0.01% 4401
2015
Q4 		$11K Sell
2,700
-54,200
-95% -$250K ﹤0.01% 4156
2015
Q3 		$261K Buy
56,900
+22,700
+66% +$119K ﹤0.01% 2310
2015
Q2 		$178K Sell
34,200
-68,000
-67% -$408K ﹤0.01% 2615
2015
Q1 		$640K Buy
102,200
+92,300
+932% +$533K 0.01% 1422
2014
Q4 		$62K Sell
9,900
-142,500
-94% -$869K ﹤0.01% 3216
2014
Q3 		$927K Sell
152,400
-84,200
-36% -$575K 0.01% 1160
2014
Q2 		$1.56M Sell
236,600
-186,400
-44% -$2.1M 0.02% 846
2014
Q1 		$10.1M Buy
423,000
+399,500
+1,700% +$5.79M 0.17% 100
2013
Q4 		$251K Sell
23,500
-6,300
-21% -$69.6K ﹤0.01% 2232
2013
Q3 		$397K Buy
29,800
+300
+1% +$4.74K 0.01% 1817
2013
Q2 		$387K Buy
+29,500
New +$398K 0.01% 1559

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Group One Trading's ECYT Position: Q4 2018 in Review

Group One Trading sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 29,231 shares — an estimated $519K sold.

Group One Trading first reported a position in ECYT in Q2 2013 and held it in 11 quarters. The position peaked at $891K in Q2 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Group One Trading reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Group One Trading sold 29,231 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $519K.
  • Group One Trading first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Endocyte, Inc. Common Stock position peaked at $891K in Q2 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.